ALK and non-small cell lung carcinoma: Unfortunately, mutational analysis of KRAS and NRAS genes was not performed for all collected NSCLC samples, and thus we could not evaluate ALK and ROS1 expression in RAS‐positive cases, which is a limitation for this study.